Ceftriaxone has also been shown effective in decreasing post‐synaptic calcium levels in PNs and improving the motor phenotype of the Afg3l2+/− mouse (SCA28 model) and a myotonic dystrophy type 1 (DM1) model.114, 120. The gene discussed is AFG3L2; the disease is myotonic dystrophy type 1.